These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 31498884)

  • 1. How I manage severe von Willebrand disease.
    Leebeek FWG; Atiq F
    Br J Haematol; 2019 Nov; 187(4):418-430. PubMed ID: 31498884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher rates of bleeding and use of treatment products among young boys compared to girls with von Willebrand disease.
    Abe K; Dupervil B; O'Brien SH; Oakley M; Kulkarni R; Gill JC; Byams V; Soucie MJ;
    Am J Hematol; 2020 Jan; 95(1):10-17. PubMed ID: 31612544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and management of von Willebrand disease].
    Higasa S; Tokugawa T; Sawada A
    Rinsho Ketsueki; 2018; 59(10):2222-2232. PubMed ID: 30305529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline factor VIII plasma levels and age at first bleeding in patients with severe forms of von Willebrand disease.
    Siboni SM; Biguzzi E; Caiani V; Mistretta C; Bucciarelli P; Peyvandi F
    Haemophilia; 2016 Jul; 22(4):564-9. PubMed ID: 26843468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of inherited von Willebrand disease in 2007.
    Federici AB; Mannucci PM
    Ann Med; 2007; 39(5):346-58. PubMed ID: 17701477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Willebrand's disease: case report and review of literature.
    Echahdi H; El Hasbaoui B; El Khorassani M; Agadr A; Khattab M
    Pan Afr Med J; 2017; 27():147. PubMed ID: 28904675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sixth Åland Island Conference on von Willebrand disease.
    Berntorp E; Trakymienė SS; Federici AB; Holstein K; Corrales-Medina FF; Pierce GF; Srivastava A; Prondzinski MVD; Johnsen JM; Zupan IP; Halimeh S; Nummi V; Roberts JC
    Haemophilia; 2022 Jul; 28 Suppl 5(Suppl 5):3-15. PubMed ID: 35861919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary issues in the management of von Willebrand disease.
    Federici AB; Königs C; James AH
    Thromb Haemost; 2016 Aug; 116 Suppl 1():S18-25. PubMed ID: 27528278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
    Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
    Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Von Willebrand Disease: Gaining a global perspective.
    O'Sullivan JM; Tootoonchian E; Ziemele B; Makris M; Federici AB; Khayat Djambas C; El Ekiaby M; Rotellini D; Sidonio RF; Iorio A; Coffin D; Pierce GF; Stonebraker J; James PD; Lavin M
    Haemophilia; 2023 Jul; 29(4):1104-1112. PubMed ID: 37216656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of replacement therapy for von Willebrand disease: From plasma fraction to recombinant von Willebrand factor.
    Peyvandi F; Kouides P; Turecek PL; Dow E; Berntorp E
    Blood Rev; 2019 Nov; 38():100572. PubMed ID: 31229334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis and von Willebrand's disease (vWD).
    Abshire TC
    Thromb Res; 2006; 118 Suppl 1():S3-7. PubMed ID: 16580053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Willebrand Disease and Pregnancy: A Review of Evidence and Expert Opinion.
    Reynen E; James P
    Semin Thromb Hemost; 2016 Oct; 42(7):717-723. PubMed ID: 27648611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of type 2b von Willebrand disease in the neonatal period.
    Proud L; Ritchey AK
    Pediatr Blood Cancer; 2017 Jan; 64(1):103-105. PubMed ID: 27468167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated overview on von Willebrand disease: focus on the interest of genotyping.
    Itzhar-Baikian N; Boisseau P; Joly B; Veyradier A
    Expert Rev Hematol; 2019 Dec; 12(12):1023-1036. PubMed ID: 31536379
    [No Abstract]   [Full Text] [Related]  

  • 16. Biological therapies for von Willebrand disease.
    Favaloro EJ; Franchini M; Lippi G
    Expert Opin Biol Ther; 2012 May; 12(5):551-64. PubMed ID: 22428722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Von Willebrand disease - the 'Dos' and 'Don'ts' in surgery.
    Miesbach W; Berntorp E
    Eur J Haematol; 2017 Feb; 98(2):121-127. PubMed ID: 27622750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of inherited von Willebrand disease: a clinical perspective.
    Federici AB
    Semin Thromb Hemost; 2006 Sep; 32(6):555-65. PubMed ID: 16977566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of von Willebrand disease with factor VIII/von Willebrand factor concentrates: results from current studies and surveys.
    Federici AB
    Blood Coagul Fibrinolysis; 2005 Apr; 16 Suppl 1():S17-21. PubMed ID: 15849522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.